Dr Reddy's Laboratories Q3 EPS $0.16, Inline, Sales $978.820M Beat $978.100M Estimate

Dr Reddy's Laboratories (NYSE:RDY) reported quarterly earnings of $0.16 per share which met the analyst consensus estimate. This is a 18.5 percent decrease over earnings of $0.20 per share from the same period last year. The company reported quarterly sales of $978.820 million which beat the analyst consensus estimate of $978.100 million by 0.07 percent. This is a 0.19 percent increase over sales of $977.000 million the same period last year.